Back icon Back Share
Helsana HealthInvest

Helsana HealthInvest

Corporate VC firm

We invest in start-ups that improve patients’ access to healthcare. We invest in companies that can demonstrate traction with a scalable business model and are already active in or want to enter the Swiss market.

Fund volume: CHF 100 million (Evergreen)
Stage: Series A to B
Initial ticket size: CHF 1–5 million
Geography: Europe, with a focus on DACH, Benelux and the Nordics
Our connection to an insurer means that we may also invest in companies in the fields of fintech, insurtech or cybersecurity.

What’s out of scope? Everything that’s clearly too early, too late, too small or too big. We don’t invest in biotechnology, life sciences or pharma.

Specification

Stages

3. Early Revenue 4. Scaling

Target countries

Germany Germany Austria Austria Switzerland Switzerland France France Italy Italy Netherlands Netherlands Belgium Belgium UK UK Denmark Denmark Sweden Sweden Norway Norway Poland Poland Spain Spain Portugal Portugal

Lead

Sometimes

Tickets

$1M to $5M

Location

Zürichstrasse 130, Dübendorf, 8600, CH, Germany

Explore similar Venture Funds to Helsana HealthInvest